Related Experiment Videos
The effects of phenylalanine on cultured rat embryos
Insights
Phenylalanine (phe) exposure during early rat embryo development did not cause malformations. However, high phe levels reduced embryonic protein and somite number, indicating potential developmental impacts.
Area of Science:
- Developmental Biology
- Biochemistry
Background:
- Maternal phenylketonuria (PKU) is linked to severe offspring developmental issues.
- Phenylalanine (phe) is suspected as the teratogenic agent in maternal PKU.
Purpose of the Study:
- To investigate if phenylalanine (phe) is the teratogenic agent in maternal phenylketonuria (PKU).
- To assess the direct effects of phe on early organogenesis and embryonic development.
Main Methods:
- Rat embryos (9.5 days) were cultured in vitro with varying phe concentrations (0.1–6.0 mM).
- Embryonic protein content and somite number were measured.
- 3H-phe uptake studies assessed phe transport into embryos.
- Amino acid analysis of exocoelomic fluid was performed.
Main Results:
- No morphological abnormalities were observed in embryos exposed to phe up to 6.0 mM.
- A significant reduction in embryonic protein content and somite number occurred at 6.0 mM phe.
- Phe was rapidly incorporated into embryonic tissues; saturation of cellular pools occurred at ≥1.4 mM phe.
- High phe levels in culture serum led to decreased concentrations of other essential amino acids in the embryo.
Conclusions:
- While phe alone did not induce malformations in early rat organogenesis, it negatively impacted embryonic growth parameters at high concentrations.
- Elevated phe levels disrupt amino acid balance within the developing embryo, potentially contributing to developmental deficits seen in maternal PKU.
Abstract:
The offspring of mothers with untreated classic phenylketonuria (PKU) have shown a high frequency of microcephaly, mental retardation, pre- and postnatal growth retardation, and birth defects. The aim of this study was to determine whether phenylalanine (phe) is the teratogenic agent in maternal PKU. To observe the direct effects of phe on organogenesis, embryos of 9.5-day pregnant rats were cultured for 48 h in the presence of phe at concentrations of 0.1 to 6.0 mM. Within this range no morphological abnormalities occurred in exposed embryos, when compared to control embryos. However there was a reduction (P less than or equal to 0.05) in embryonic protein content and somite number at the highest concentration of phe (6.0 mM). This does not preclude the longer-term effects of phe at later stages of gestation. To examine phe transport into the embryo in response to elevated serum phe levels, 3H-phe uptake studies were undertaken. These showed that 3H-phe from the culture serum is incorporated rapidly into the free amino acid pools and embryonic protein. At serum concentrations of 1.4 mM or higher, phe saturation occurs in the cellular pools of the embryo. Amino acid analysis of the exocoelomic fluid showed that when embryos were cultured for 48 h in serum containing 3.45 mM phe, the total amino acid concentration was maintained near the control levels (16 mM). Of this, 27% (4.26 mM) was contributed by phe, and all other amino acids, except methionine, were decreased with respect to control levels.